Description     Claims     Drawing  

EP2008066457W   [0004] 
EP2008066468W   [0005] 
US14187841B   [0239] 

the International Standards for Neurological Classification of Spinal Cord Injury   [0028] 
CHEMICAL ABSTRACTS   [0032]  [0033] 
CHEMICAL ABSTRACTS   [0032]  [0033] 
CHEMICAL ABSTRACTS   [0032]  [0033] 
CHEMICAL ABSTRACTS   [0032]  [0033] 
CHEMICAL ABSTRACTS   [0032]  [0033] 
CHEMICAL ABSTRACTS   [0032]  [0033] 
CHEMICAL ABSTRACTS   [0032]  [0033] 
CHEMICAL ABSTRACTS   [0032]  [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
CHEMICAL ABSTRACTS   [0033] 
The Science and Practice of Pharmacy   [0067] 
Encyclopedia of Pharmaceutical Technology   [0067] 
Encyclopedia of Pharmaceutical Technology   [0074] 
Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina   [0238] 
Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice   [0238] 
Proliferation of Schwann Cells and Regulation of Cyclin D1 Expression in an Animal Model of Charcot-Marie-Tooth Disease Type 1A   [0238] 
Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner   [0238] 
Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells   [0238] 
Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes   [0238] 
Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22   [0238] 
Cyclooxygenase-2 and Colorectal Cancer Chemoprevention: The β-Catenin Connection   [0238] 
A mixed model approach for intent-to-treat analysis in longitudinal clinical trials with missing values   [0238] 
Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury   [0238] 
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22   [0238] 
DMSO induction of the leukotriene LTC4 by Lewis rat Schwann cells   [0238] 
The Neurotrophin Receptor p75NTR as a Positive Modulator of Myelination   [0238] 
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial   [0238] 
Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA   [0238] 
PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats   [0238] 
Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients   [0238] 
Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin   [0238] 
Emerging role for autophagy in the removal of aggresomes in Schwann cells   [0238] 
Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model   [0238] 
Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression   [0238] 
The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones   [0238] 
Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment   [0238] 
Aldose reductase induced by hyperosmotic stress mediates cardiomyocyte apoptosis: differential effects of sorbitol and mannitol   [0238] 
A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale   [0238] 
Expression and functional state of the corticosteroid receptors and 11 beta-hydroxysteroid dehydrogenase type 2 in Schwann cells   [0238] 
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)   [0238] 
GISP: a novel brain-specific protein that promotes surface expression and function of GABA(B) receptors   [0238] 
The Journal of Spinal Cord Medicine   [0238] 
Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy   [0238] 
Evidence for Macrophage-Mediated Myelin Disruption in an Animal Model for Charcot-Marie-Tooth Neuropathy Type 1A   [0238] 
Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome   [0238] 
Identifying blood biomarkers for mood disorders using convergent functional genomics   [0238] 
Muscle Study Group. High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A: Results of a Randomized, Double-Masked, Controlled Trial   [0238] 
Induction of type 3 iodothyronine deiodinase by nerve injury in the rat peripheral nervous system   [0238] 
Statistical Analysis with Missing Data   [0238] 
On O ' Brien ' s OLS and GLS tests for multiple endpoints   [0238] 
Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A   [0238] 
Conditions for the Effectiveness of a Preliminary Test of Variance   [0238] 
Disease progression of human SOD1 (G93A) transgenic ALS model rats   [0238] 
Role of immune cells in animal models for inherited neuropathies: facts and visions   [0238] 
Peripheral nerves: a target for the action of neuroactive steroids   [0238] 
Rapid effects of triiodothyronine on immediate-early gene expression in Schwann cells   [0238] 
Animal models of inherited neuropathies   [0238] 
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy   [0238] 
Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells   [0238] 
Identification and functional characterization of thromboxane A2 receptors in Schwann cells   [0238] 
In vivo Regulation of Extracellular Signal-Regulated Protein Kinase (ERK) and Protein Kinase B (Akt) Phosphorylation by Acute and Chronic Morphine   [0238] 
Attenuation of aldose reductase gene suppresses high-glucose-induced apoptosis and oxidative stress in rat lens epithelial cells   [0238] 
Mechanisms of disease: inherited demyelinating neuropathies-from basic to clinical research   [0238] 
CMT rat'': peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22   [0238] 
Upregulation of the endosomal-lysosomal pathway in the trembler-J neuropathy   [0238] 
Procedures for Comparing Samples with Multiple Endpoints   [0238] 
GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons   [0238] 
Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination   [0238] 
Peripheral myelin protein 22 is expressed in human central nervous system   [0238] 
Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy   [0238] 
Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease   [0238] 
Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A   [0238] 
Pharmacological induction of the heat shock response improves myelination in a neuropathic model   [0238] 
Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene   [0238] 
PMP22 overexpression causes dysmyelination in mice   [0238] 
Synthesis of progesterone in Schwann cells: regulation by sensory neurons   [0238] 
The temporospatial expression of peripheral myelin protein 22 at the developing blood-nerve and blood-brain barriers   [0238] 
Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A   [0238] 
A more realistic look at the robustness and Type II error properties of the t test to departures from population normality   [0238] 
Progesterone synthesis and myelin formation in peripheral nerves   [0238] 
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)   [0238] 
Animal models of Charcot-Marie-Tooth disease type 1A (CMT1A)   [0238] 
Reliability and validity of the CMT neuropathy score as a measure of disability   [0238] 
Muscarinic M2 receptors mediate transactivation of EGF receptor through Fyn kinase and without matrix metalloproteases   [0238] 
Disease mechanisms in inherited neuropathies   [0238] 
Trembler mouse carries a point mutation in a myelin gene   [0238] 
Identification of early disease progression in an ALS rat model   [0238] 
The phenotypic manifestations of chromosome 17p 11.2 duplication   [0238] 
Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22   [0238] 
Dominant role of GABAB2 and Gbetagamma for GABAB receptor-mediated-ERK1/2/CREB pathway in cerebellar neurons   [0238] 
Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element   [0238] 
Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants   [0238] 
Ultrastructural PMP22 expression in inherited demyelinating neuropathies   [0238] 
Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data. BMC Med   [0238] 
Nuclear triiodothyronine receptor expression is regulated by axon-Schwann cell contact   [0238] 
Differential expression of triiodothyronine receptors in schwannoma and neurofibroma: role of Schwann cell-axon interaction   [0238] 
Influence of molecular and chemical chaperones on protein folding   [0238] 
Localisation and modulation of prostanoid receptors EP1 and EP4 in the rat chronic constriction injury model of neuropathic pain   [0238]